Relay Therapeutics Inc (RLAY)
6.43
+0.13
(+2.06%)
USD |
NASDAQ |
May 31, 16:00
6.415
-0.02
(-0.23%)
After-Hours: 20:00
Relay Therapeutics Revenue (Quarterly): 10.01M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 10.01M |
| December 31, 2023 | -0.001M |
| September 30, 2023 | 25.20M |
| June 30, 2023 | 0.119M |
| March 31, 2023 | 0.226M |
| December 31, 2022 | 0.253M |
| September 30, 2022 | 0.344M |
| Date | Value |
|---|---|
| June 30, 2022 | 0.365M |
| March 31, 2022 | 0.419M |
| December 31, 2021 | 0.567M |
| September 30, 2021 | 0.666M |
| June 30, 2021 | 0.844M |
| March 31, 2021 | 0.952M |
| December 31, 2020 | 82.65M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-0.001M
Minimum
Dec 2023
82.65M
Maximum
Dec 2020
8.758M
Average
0.493M
Median
Revenue (Quarterly) Benchmarks
| Olema Pharmaceuticals inc | -- |
| Moderna Inc | 167.00M |
| Exelixis Inc | 425.23M |
| Geron Corp | 0.304M |
| Regeneron Pharmaceuticals Inc | 3.145B |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -81.39M |
| Total Expenses (Quarterly) | 102.20M |
| EPS Diluted (Quarterly) | -0.62 |
| Enterprise Value | 103.92M |
| Profit Margin (Quarterly) | -813.3% |
| Earnings Yield | -41.06% |
| Normalized Earnings Yield | -41.96 |